BOOST Pharma has been selected as a 2026 Innovation Spotlight company at the Cell & Gene Meeting on the Mesa, where CEO Hans Schambye will present an update on BT-101 and preparations for its planned pivotal Phase III study.
Presentation Details
Date and Time: Tuesday, 6 October 2026, at 11:00 a.m. MST
Track: Innovation Spotlight Showcase
Location: FLW Ballroom G, Arizona Biltmore Hotel
Presenter: Hans Schambye, Chief Executive Officer, BOOST Pharma
Ahead of the Cell & Gene Meeting on the Mesa, Hans will also attend the Alliance for Regenerative Medicine CEO Summit in Phoenix on October 4, 2026, where he will meet with investors and potential partners.